QTc prolongation with concurrent use of azithromycin and diltiazem in an old female patient: a case report
Journal: International Journal of Basic & Clinical Pharmacology (Vol.3, No. 1)Publication Date: 2014-02-01
Authors : Lama Soubra Ali Mroueh Samer Kabbani;
Page : 242-246
Keywords : Azithromycin; Diltiazem; Drug Interaction; QTc prolongation; Torsade de pointes; Cardiac arrest;
Abstract
Azithromycin is widely prescribed for the treatment of respiratory tract infections. Incidence of corrected QT interval (QTc) prolongation and cardiac arrest has not been reported after concomitant administration of azithromycin and diltiazem. Here we present a 69-year-old female patient who developed profound QTc prolongation and cardiac arrest after three days of concomitant administration of azithromycin and diltiazem. The patient was successfully resuscitated, intravenous magnesium was given and azithromycin therapy was discontinued. The QTc interval dropped to 412 ms 24 hours after azithromycin discontinuation. One week later, the patient was discharged home after full recovery. This case illustrates a possible drug interaction between azithromycin and P-glycoprotein inhibitor drugs and/or drugs having an effect on cardiac repolarization. [Int J Basic Clin Pharmacol 2014; 3(1.000): 242-246]
Other Latest Articles
- A case of Stevens-Johnson syndrome due to rifampicin
- Metronidazole associated seizures: a case report and review of the pharmacovigilance literature
- Antipsychotic discontinuation syndrome following risperidone withdrawal: a case report from rural India
- Alcoholism with central pontine demyelination: a case report
- Serotonin syndrome due to fluoxetine and tramadol in renal impaired patient
Last modified: 2014-02-08 13:55:53